Blackstone: Be Greedy When Others Are Fearful

Blackstone’s Q1 fundamentals were strong, with inflows rising to $68.5B and fee-related earnings up 23% YoY to $1.55B. Distributable EPS increased 25% to $1.36, while credit & insurance inflows climbed 22% YoY and dry powder reached $213.3B. Despite recent private credit concerns and share underperformance since January, the article argues the stock remains supported by robust operating trends.

Analysis

BX is signaling that the private markets drawdown is becoming a relative-share story rather than a fundamentals story. The key second-order effect is that persistent AUM growth plus a large capital overhang should let BX take share from smaller credit managers that lack balance-sheet flexibility, tighter fundraising networks, and the ability to warehouse risk when spreads widen. If financing markets stay orderly, the firm can monetize dislocation first, which typically compounds into higher fee-related earnings before realized performance fees show up.

The market is likely still pricing BX through the lens of “private credit stress,” but the setup looks more like a duration mismatch in sentiment than in cash flow. Near-term downside comes from any widening in credit spreads that slows fundraising velocity or increases mark-to-market pressure on portfolio marks; that risk matters most over the next 1-2 quarters, not years. The more dangerous version is not loan losses, but a prolonged freeze in LP appetite that would cap deployment and delay fee growth even if headline earnings remain resilient.

The underappreciated bullish angle is that BX’s capital base becomes more valuable if exit markets remain sluggish. In that regime, scaled platforms with dry powder can step in as preferred providers of rescue capital, GP-led solutions, and structured credit, which tends to shift economics away from competitors and toward the largest managers. That creates a reinforcing loop: better deployment opportunities support future inflows, and future inflows support multiple re-rating.

Consensus may be underestimating how much of the recent underperformance is driven by positioning rather than fundamentals. If the next quarter confirms stable fundraising and no material deterioration in credit losses, BX can rerate quickly because a lot of investors are still waiting for a “hard evidence” inflection that may never arrive. The risk/reward looks asymmetric if the stock is already discounting a larger credit event than the data currently implies.

Key Decisions for Investors

• Go long BX on weakness over the next 1-3 weeks; target a 10-15% rebound if private credit fears ease and fundraising momentum stays intact. Use a tight 6-8% stop if credit spreads or high-yield ETFs start breaking out materially.
• Pair trade: long BX / short a smaller private credit or alt-manager peer with less scale and weaker fundraising diversification for 1-2 quarters. The thesis is that capital concentration favors the platform with the deepest dry powder and strongest distribution.
• Buy BX calls 3-6 months out, ideally using a call spread to finance upside into the next earnings cycle. This is attractive if the market is mispricing the probability of a clean sequential beat in fee-related earnings.
• For more conservative exposure, wait for any 2-3 day selloff tied to broader credit headlines before entering. The setup is better after fear spikes than chasing strength, because the catalyst path is confirmation rather than surprise.
• If spreads widen sharply and management commentary turns defensive, trim quickly; the main risk is not valuation compression alone but a fundraising air pocket that could persist 2+ quarters.